Northwind Biosciences
At risk40/100SmallBiotechnology
About this account
Seed-stage biotech, pre-IND, first-time FDA filer.
Relationship health
40/100 · At riskHow this account's health has moved over the last 5 weeks.
100 pts0 pts
4w ago2w agothis week
How touches have landed
Every logged touch with Northwind Biosciences, by outcome.
No activity yet
The first call, email, meeting, or note will build this account's outcome mix.
Company profile
Not analyzed yet — analyze to qualify its type, ownership and revenue from the web, and the offerings that fit show automatically.
Agent briefing
Northwind Biosciences needs attention — at risk, with $125K in open pipeline at stake. It's single-threaded, so widening the relationship would de-risk the deal. Recommended next move: Stabilize Northwind Biosciences.
HealthAt risk (40/100).
Pipeline1 open deal worth $125K.
ThreadingSingle-threaded on Owen Bradley — widen the relationship to de-risk.
MomentumNo activity logged yet — open the relationship.
Recommended: Stabilize Northwind Biosciences
Key Contacts
Value PropositionsAI generated
Clinical Trial Regulatory Support70% match
Position Clinical Trial Regulatory Support against Northwind Biosciences's near-term regulatory milestones.
Matched from your Freyr knowledge base
Regulatory Intelligence50% match
Single-pane monitoring across FDA, EMA and 120+ agencies.
Matched from your Freyr knowledge base
Angles to researchAI generated
Agent-suggested things worth checking before you reach out — verify before you rely on them.
Regulatory
Check for recent Biotechnology guidance that could tighten their submission timelines — a timely reason to reach out.
Hiring
See whether Northwind is hiring in regulatory affairs — a growing team often means more submission workload they may need help with.